Patents by Inventor Mohan R. Kaadige

Mohan R. Kaadige has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250092018
    Abstract: Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).
    Type: Application
    Filed: September 30, 2024
    Publication date: March 20, 2025
    Inventors: Srinivas Rao Kasibhatla, Raman Kumar Kalakuntla, Alexis Weston, Trason Thode, Sunil Sharma, Mohan R. Kaadige
  • Patent number: 12152015
    Abstract: Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: November 26, 2024
    Assignee: STINGRAY THERAPEUTICS, INC.
    Inventors: Srinivas Rao Kasibhatla, Raman Kumar Kalakuntla, Alexis Weston, Trason Thode, Sunil Sharma, Mohan R. Kaadige
  • Publication number: 20230183212
    Abstract: Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).
    Type: Application
    Filed: February 14, 2023
    Publication date: June 15, 2023
    Inventors: Srinivas Rao Kasibhatla, Raman Kumar Kalakuntla, Alexis Weston, Trason Thode, Sunil Sharma, Mohan R. Kaadige
  • Patent number: 11591313
    Abstract: Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: February 28, 2023
    Assignee: STINGRAY THERAPEUTICS, INC.
    Inventors: Srinivas Rao Kasibhatla, Raman Kumar Kalakuntla, Alexis Weston, Trason Thode, Sunil Sharma, Mohan R. Kaadige
  • Publication number: 20210253556
    Abstract: Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).
    Type: Application
    Filed: February 4, 2021
    Publication date: August 19, 2021
    Inventors: Srinivas Rao Kasibhatla, Raman Kumar Kalakuntla, Alexis Weston, Trason Thode, Sunil Sharma, Mohan R. Kaadige